| 注册
首页|期刊导航|转化医学杂志|活血化瘀中药与抗血小板药物联用治疗冠心病的研究

活血化瘀中药与抗血小板药物联用治疗冠心病的研究

吕仕超 张军平

转化医学杂志Issue(3):158-161,179,5.
转化医学杂志Issue(3):158-161,179,5.DOI:10.3969/j.issn.2095-3097.2014.03.009

活血化瘀中药与抗血小板药物联用治疗冠心病的研究

The research of "blood activating and stasis-removing"in traditional Chinese medicine and antiplatelet drug for treatment of coronary heart disease

吕仕超 1张军平1

作者信息

  • 1. 300193 天津,天津中医药大学第一附属医院老年病科
  • 折叠

摘要

Abstract

Coronary heart disease is one of the common clinical cardiovascular disease , its rate of prevalence is rising.Antiplatelet therapy is the most important treatment of coronary heart di -sease, which can effectively reduce the incidence of cardiovascular events .Although percutaneous coronary intervention(PCI) open up a new situation in the treatment of coronary heart disease , anti-platelet therapy is essential before and after intervention .With the widespread using of antiplatelet drugs, the decline of resistant phenomenon and non -specific therapeutic response gradually attracted attention, but the combine of therapy lead to increases of bleeding and other side effects .Due to the effective efficacy and less side effects of "Blood Activating and Stasis-removing"traditional Chinese medicine (TCM) in the treatment of coronary heart disease, therefore, the majority of clinical coronary heart disease patients take one kind of "Blood Activating and Stasis-removing"TCM at least,someone even take multiple.However, it still need multiple samples, multi-center and randomized controlled trial study to evaluate the efficacy and safety of the "Blood activating and Stasis-removing"TCM and the antiplatelet drug in treatment of coronary heart disease .Further more, the mechanism of "blood activating and stasis-removing"TCM and the interactive relationship of it with antiplatelet drug in treating coronary heart disease should be definitude , which can provide reference to guide clinical rational and standard drug application .

关键词

冠心病/经皮冠状动脉介入治疗/中药/抗血小板

Key words

Coronary heart disease/Percutaneous coronary intervention (PCI)/Traditional Chinese medicine (TCM)/Antiplatelet

分类

医药卫生

引用本文复制引用

吕仕超,张军平..活血化瘀中药与抗血小板药物联用治疗冠心病的研究[J].转化医学杂志,2014,(3):158-161,179,5.

转化医学杂志

2095-3097

访问量0
|
下载量0
段落导航相关论文